Life Science Institute to Begin Exploratory Study of Muse Cell Therapy for COVID-19-Associated ARDS

April 21, 2021
Life Science Institute President Seiichi Kiso (right) and Shogo Nakamori, Head of R&D Division (Courtesy of Life Science Institute) Life Science Institute, a Mitsubishi Chemical group company, will kick off a Japanese exploratory clinical study of its multi-lineage differentiating stress...read more